Investigation of the Effect of Oral Treatment With 100 mg AZD2423 in Subjects With Mild Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT01153321 · COMPLETED
Trial details
- NCT number
- NCT01153321
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2011-07-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.